Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Peanut Allergy Alert: Western Mixers Recalls First Street Dark Chocolate Raisins Over Undeclared Allergen
ONTARIO, Calif. – June 16, 2026 – Western Mixers Produce & Nuts, Inc. has issued a voluntary recall of its First Street brand Dark Chocolate Raisins after discovering the 9-ounce containers may contain undeclared peanuts, posing a potentially life-threatening risk to consumers with peanut allergies.
The recall, announced publicly by the FDA on Tuesday, specifically targets products with Lot Code #260562 and UPC 7-97565-01183-0. The affected containers are packed in clear plastic and were distributed exclusively to Chedraui USA, where they were sold at Smart & Final stores throughout California.
The company identified the problem after it was discovered that the dark chocolate raisins may have been cross-contaminated with dark chocolate peanuts, an allergen not listed on the product label. People who have a severe sensitivity to peanuts and consume the affected product face the risk of serious or fatal allergic reactions.
To date, Western Mixers reports that no illnesses have been linked to the recalled product. However, the company is urging consumers with peanut allergies to immediately discard any raisins matching the lot number or return the item to the place of purchase for a full refund.
“As a precaution, we are recalling all supplies of the food with the above identification,” the company stated in its official announcement.
The recall affects only the 9-ounce First Street Dark Chocolate Raisins with the specified lot code. Consumers without peanut allergies are not at risk and may consume the product as usual. However, the company advises that anyone who purchased the item and has an allergy should not eat it under any circumstances.
Customers seeking more information can contact Western Mixers Produce & Nuts, Inc.’s Food Safety Department directly at 323-443-2567.
This recall highlights the ongoing challenge of undeclared allergens in packaged foods, a leading cause of FDA-regulated food recalls. The FDA continues to monitor the situation, and the company is cooperating fully with the agency to ensure all affected products are removed from store shelves.
Nationwide Infant Formula Recall Triggered by Three Hospitalizations in Botulism Scare
NEW YORK – June 13, 2026 – Nara Organics has issued an urgent nationwide recall of all lots of its powdered infant formula after federal health officials linked the product to three cases of infant botulism in California, Washington, and Pennsylvania, prompting fears of a potentially fatal outbreak among the country’s most vulnerable consumers.
The voluntary recall, announced in coordination with the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), covers every lot of Nara Organics Whole Milk Powdered Infant Formula currently on the market. The product was distributed nationally through Target retail stores, Target.com, and the company’s own website between July 2025 and June 2026.
The three infants who fell ill were hospitalized and treated with BabyBIG (Botulism Immune Globulin Intravenous), a specialized treatment for infant botulism. All three have survived, and no deaths have been reported. However, the CDC confirmed that each of the affected infants had consumed Nara formula prior to becoming sick. The specific lots linked to the cases are:
- 408125075E14F2
- 708125076E14F2
- 708125083E14F2
- 408125139E14F2
- 708125141E14F2
- 708125145E14F2
- 708125174E14F2
- 709125273E14F2
- 709125280E14F2
- 709125288E14F2
- 409125307E14F2
- 70926019ENNB
- 70926029ENNB
- 70926035ENNB
- 70926039ENNB
- 70926042ENNB
While Nara Organics stated that its formula has not tested positive for Clostridium botulinum to date, the company is recalling all lots currently in circulation out of an abundance of caution. The complete list of recalled lot codes—which can be found on the bottom of each can—includes more than a dozen codes across 700g and 400g containers.
A Race Against Time for Infants
Infant botulism occurs when C. botulinum spores are ingested and colonize a baby’s immature intestinal tract, producing neurotoxins that can lead to paralysis and respiratory arrest. Symptoms parents are urged to watch for include:
- Constipation
- Poor feeding and difficulty sucking or swallowing
- Drooping eyelids (ptosis) and sluggish pupils
- Low muscle tone (“floppy baby” syndrome)
- Weak or altered cry
- Generalized weakness
- Respiratory difficulty
“If your baby has consumed this product and is presenting any of these symptoms, contact your healthcare provider immediately for emergency care,” the company warned in its official statement.
Aggressive Action and Refund Process
Nara stated it is working closely with the FDA, CDC, and state health agencies to investigate the root cause of the contamination. The company described its response as “aggressive action” to protect families, pledging transparency as the investigation unfolds.
Customers are instructed to stop using the affected products immediately. Nara has automatically begun refunding all consumers who purchased formula directly from its website in May and June 2026. Customers with unused product from other retailers can request a refund by submitting a photo of the can’s bottom via a dedicated refund form on Nara’s website. Target customers may also return products to any Target store or follow the retailer’s online return policy.
Widespread Distribution, No International Sales
The recalled formula is sold in 700g and 400g cans with UPCs 860013251901 and 860013251918, respectively. Nara confirmed that the product was not distributed outside the United States.
The company issued a sincere apology to its customers, acknowledging the distress caused by the recall. “We are committed to leading with transparency and accountability throughout this process,” the statement read.
For questions or concerns, consumers are directed to visit Nara’s website or email hello@nara.com. Adverse reactions or illnesses can also be reported directly to the FDA through the MedWatch program.
This recall comes as a stark reminder of the severe risks associated with contaminated infant formula, following high-profile national shortages and safety scares in recent years. Health officials continue to urge vigilance, emphasizing that infant botulism is a medical emergency requiring immediate intervention.
About the Author
